NCT06095089View on ClinicalTrials.gov

A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

June 21, 2027

Study Completion Date

October 27, 2027

Conditions
Advanced Prostate Cancer
Interventions
DRUG

JNJ-78278343

JNJ-78278343 will be administered.

DRUG

JNJ-87189401

JNJ-87189401 will be administered.

Trial Locations (5)

10032

RECRUITING

Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York

69008

RECRUITING

Centre Leon Berard, Lyon

78229

RECRUITING

South Texas Accelerated Research Therapeutics, LLC (START), San Antonio

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

94800

RECRUITING

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY